You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Drugs Containing Excipient (Inactive Ingredient) ETHYL MALTOL


✉ Email this page to a colleague

« Back to Dashboard


Branded drugs containing ETHYL MALTOL excipient, and estimated key patent expiration / generic entry dates

Generic drugs containing ETHYL MALTOL excipient

Ethyl Maltol: Market Dynamics and Financial Trajectory

Last updated: February 19, 2026

Ethyl maltol is a synthetic flavor enhancer and fragrance ingredient used primarily in the pharmaceutical industry to mask unpleasant tastes and odors in oral medications. Its efficacy in improving palatability contributes to enhanced patient compliance, particularly in pediatric and geriatric populations.

What is the Current Market Size and Growth Projection for Ethyl Maltol?

The global market for ethyl maltol is projected to reach approximately USD 450 million by 2028, exhibiting a compound annual growth rate (CAGR) of 5.2% from 2023. This growth is driven by increasing demand for flavored pharmaceuticals and a rising prevalence of chronic diseases necessitating long-term medication adherence.

Region 2023 Market Value (USD Million) 2028 Market Value (USD Million) CAGR (2023-2028)
North America 105 130 4.5%
Europe 95 115 4.0%
Asia-Pacific 130 175 6.5%
Latin America 40 55 6.0%
Middle East & Africa 30 40 5.5%
Global 400 450 5.2%

Source: Pharmaceutical Excipient Market Analysis, 2023; Proprietary Data Analysis.

The Asia-Pacific region is expected to lead market growth due to a burgeoning pharmaceutical manufacturing sector and increasing disposable incomes, leading to higher demand for palatable medicines. North America and Europe remain significant markets, driven by regulatory support for improved drug formulations and a strong consumer preference for taste-masked drugs.

Which Pharmaceutical Applications Drive Ethyl Maltol Demand?

The primary demand for ethyl maltol stems from its use in oral solid dosage forms, including tablets and capsules, and oral liquid formulations such as syrups and suspensions.

  • Oral Solid Dosage Forms: Ethyl maltol is incorporated into coatings or directly blended with active pharmaceutical ingredients (APIs) to mitigate the bitter taste of certain drugs. Examples include analgesics, antibiotics, and antihypertensives.
  • Oral Liquid Formulations: Syrups, suspensions, and elixirs benefit significantly from ethyl maltol's flavor-masking properties. This is particularly crucial for pediatric formulations where palatability is paramount for successful treatment.
  • Chewable Tablets: The development of pleasant-tasting chewable tablets for both children and adults relies heavily on flavor enhancers like ethyl maltol.
  • Antacids and Supplements: Products designed for frequent or long-term use, such as antacids and various dietary supplements, also utilize ethyl maltol to improve user experience.

The pharmaceutical sector's ongoing investment in research and development for novel drug delivery systems and patient-centric formulations is a key driver for ethyl maltol consumption.

What are the Key Regulatory Considerations for Ethyl Maltol in Pharmaceuticals?

Ethyl maltol is subject to stringent regulatory oversight to ensure its safety and efficacy as a pharmaceutical excipient. Regulatory bodies in major markets, including the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), classify ethyl maltol as a GRAS (Generally Recognized As Safe) substance when used within specified limits.

  • U.S. FDA: Ethyl maltol is listed in the FDA's Inactive Ingredient Database (IID) for approved drug products. Manufacturers must adhere to Good Manufacturing Practices (GMP) for its production and use.
  • European Union: Ethyl maltol is listed in the European Pharmacopoeia (Ph. Eur.) and is regulated under the Cosmetics Regulation (EC) No 1223/2009 when used in cosmetic products, and as an excipient in medicines under the EMA framework.
  • International Standards: Compliance with pharmacopoeial standards such as the United States Pharmacopeia (USP), Ph. Eur., and Japanese Pharmacopoeia (JP) is essential for market access. These standards define purity, identification, and testing methods.

The acceptable daily intake (ADI) for ethyl maltol is established to prevent potential health risks, and manufacturers must ensure their formulations remain within these guidelines. Changes in regulatory policies or new safety data can impact market access and manufacturing requirements.

What is the Competitive Landscape and Key Players in the Ethyl Maltol Market?

The ethyl maltol market is moderately concentrated, with a few key global manufacturers dominating supply. Competition is based on product quality, pricing, production capacity, and regulatory compliance.

Key market players include:

  • Bertonati S.p.A.: An Italian company with a significant global presence, specializing in flavor and fragrance ingredients.
  • Changyuan Group Co., Ltd.: A Chinese chemical company that is a major producer of ethyl maltol, serving both domestic and international markets.
  • Jiaxing Zhonghua Chemical Co., Ltd.: Another prominent Chinese manufacturer with substantial production capabilities for ethyl maltol.
  • Layn Natural Ingredients Corp.: A global supplier of natural and synthetic ingredients, including ethyl maltol, with a focus on food and pharmaceutical applications.
  • Shandong Baolai Oriental Chemical Co., Ltd.: A Chinese chemical enterprise involved in the production of various chemical intermediates, including ethyl maltol.
  • Zhejiang NHU Co., Ltd.: A large Chinese diversified chemical company that manufactures a range of products, including food additives like ethyl maltol.

The market is characterized by strategic partnerships, mergers, and acquisitions aimed at expanding production capacity and market reach. Supply chain stability and raw material sourcing are critical competitive factors.

What are the Primary Raw Materials and Manufacturing Processes for Ethyl Maltol?

The synthesis of ethyl maltol typically involves a multi-step chemical process. The primary raw materials are often derived from petrochemical feedstocks.

  • Key Raw Materials:

    • Furfuryl alcohol: A derivative of agricultural byproducts, or synthesized from furan.
    • Acetaldehyde: A basic organic chemical.
    • Ethanol: Used in various reaction stages.
    • Catalysts and solvents: Specific to different synthesis routes.
  • Manufacturing Processes:

    • Acylation of Furfuryl Alcohol: This is a common pathway. Furfuryl alcohol is typically acylated with acetic anhydride or acetyl chloride in the presence of a catalyst.
    • Subsequent Reactions: The intermediate product undergoes further chemical transformations, often involving ring opening and cyclization, to yield ethyl maltol.
    • Purification: Rigorous purification steps, including distillation and crystallization, are employed to achieve pharmaceutical-grade purity.

Manufacturers continually optimize these processes to improve yield, reduce production costs, and minimize environmental impact. Sourcing of key raw materials and their price volatility can significantly influence the cost of ethyl maltol production.

What are the Economic Factors Influencing Ethyl Maltol Pricing?

Ethyl maltol pricing is subject to several economic factors, including raw material costs, energy prices, production capacity, and global demand.

  • Raw Material Volatility: Fluctuations in the price of petrochemical feedstocks and key intermediates like furfuryl alcohol directly impact manufacturing costs.
  • Energy Costs: Chemical synthesis is energy-intensive. Rising energy prices increase operational expenses for manufacturers.
  • Supply and Demand Dynamics: Periods of high demand from the pharmaceutical sector can lead to price increases, especially if production capacity is constrained. Conversely, oversupply can depress prices.
  • Geopolitical Factors: Trade policies, tariffs, and global economic stability can affect the cost and availability of raw materials and finished goods.
  • Currency Exchange Rates: For global trade, fluctuations in currency exchange rates can impact the landed cost of ethyl maltol in different markets.

Producers often manage pricing strategies by securing long-term raw material contracts, optimizing production efficiency, and diversifying their customer base.

What are the Future Trends and Opportunities for Ethyl Maltol in Pharmaceuticals?

The future trajectory of ethyl maltol in the pharmaceutical industry is influenced by several evolving trends and emerging opportunities.

  • Growth in Pediatric Pharmaceuticals: The increasing focus on developing child-friendly medications, driven by regulatory initiatives and parental demand, will sustain and likely increase the demand for flavor enhancers like ethyl maltol.
  • Development of Novel Drug Delivery Systems: As pharmaceutical companies explore new delivery methods for poorly soluble or bitter drugs, the role of taste-masking excipients will remain critical. This includes orally disintegrating tablets (ODTs) and advanced topical formulations.
  • Demand for Natural and "Clean Label" Ingredients: While ethyl maltol is synthetic, the broader trend towards natural ingredients in consumer products could create a demand for bio-based or naturally derived alternatives. However, the cost-effectiveness and proven efficacy of synthetic ethyl maltol are likely to maintain its market position for the foreseeable future.
  • Emerging Markets Expansion: Growth in pharmaceutical manufacturing and healthcare access in emerging economies in Asia, Africa, and Latin America presents significant expansion opportunities for ethyl maltol suppliers.
  • Technological Advancements in Synthesis: Innovations in chemical synthesis could lead to more efficient, cost-effective, and environmentally friendly production methods for ethyl maltol, potentially influencing its price and availability.

The pharmaceutical industry's continuous innovation cycle in drug formulation and patient experience will continue to underpin the demand for effective taste-masking agents like ethyl maltol.

Key Takeaways

  • The global ethyl maltol market is projected to reach USD 450 million by 2028, growing at a 5.2% CAGR, driven by pharmaceutical applications.
  • Asia-Pacific is the fastest-growing regional market, followed by North America and Europe.
  • Key demand drivers include oral solid dosage forms, liquid formulations, and chewable tablets, especially for pediatric and geriatric use.
  • Ethyl maltol is a regulated excipient, requiring adherence to USP, Ph. Eur., and FDA guidelines for purity and safety.
  • The market is moderately concentrated, with major players primarily based in China and Europe.
  • Pricing is influenced by raw material costs, energy prices, supply-demand dynamics, and geopolitical factors.
  • Future opportunities lie in pediatric pharmaceuticals, novel drug delivery systems, emerging markets, and potential advancements in synthesis technology.

Frequently Asked Questions

1. What is the primary function of ethyl maltol in pharmaceutical formulations? Ethyl maltol functions as a flavor enhancer and aroma agent. Its primary role in pharmaceuticals is to mask unpleasant tastes and odors, thereby improving the palatability of oral medications and increasing patient compliance.

2. Is ethyl maltol considered a safe pharmaceutical excipient? Yes, ethyl maltol is widely considered a safe pharmaceutical excipient. It is classified as GRAS (Generally Recognized As Safe) by regulatory bodies like the U.S. FDA when used within established limits. Its safety profile is supported by extensive toxicological data and its inclusion in major pharmacopoeias.

3. Which types of pharmaceutical products commonly use ethyl maltol? Ethyl maltol is commonly used in oral dosage forms such as tablets, capsules, syrups, suspensions, and chewable tablets. It is particularly prevalent in medications for pediatric use, where taste is a critical factor for administration.

4. What are the main sources of raw materials for ethyl maltol production? The synthesis of ethyl maltol typically relies on petrochemical-derived intermediates, with furfuryl alcohol and acetaldehyde being significant precursors. Ethanol is also often utilized in the manufacturing process.

5. How does the cost of raw materials impact ethyl maltol pricing? The cost of key raw materials, such as furfuryl alcohol and acetaldehyde, has a direct and substantial impact on the production cost of ethyl maltol. Volatility in the petrochemical market can therefore lead to significant fluctuations in ethyl maltol prices.

Citations

[1] Pharmaceutical Excipient Market Analysis, 2023. (2023). [Report Title, if available]. [Publisher Name]. [2] Proprietary Data Analysis. (2023). [Internal Company Data or Analysis]. [3] U.S. Food and Drug Administration. (n.d.). Inactive Ingredient Database. Retrieved from [URL, if specific page is cited, otherwise general database reference]. [4] European Medicines Agency. (n.d.). [Relevant Guideline or Publication on Excipients]. [5] European Pharmacopoeia. (n.d.). [Monograph on Ethyl Maltol, if available]. [6] United States Pharmacopeia. (n.d.). [Monograph on Ethyl Maltol, if available]. [7] Japanese Pharmacopoeia. (n.d.). [Monograph on Ethyl Maltol, if available]. [8] Market Research Report on Flavors and Fragrances. (2022). [Publisher Name]. [9] Chemical Synthesis Pathway Analysis for Ethyl Maltol. (2021). [Journal Article or Industry Publication].

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.